Holly Thompson

Holly Thompson
Contributor since: 2010
Company: Thompson Wealth Management
1/23/14
Holly Thompson
McDonald's $MCD reports Q4 earnings of $1.40/sh, $.01 better than estimate. Revs rose 2.0% yr/yr to $7.09 bln vs the $7.11 bln consensus.
1/23/14
Holly Thompson
Norfolk Southern $NSC target raised to $110 from $98 at Cowen.
1/23/14
Holly Thompson
Long hours & a fractious relationship with Pimco's founder prompted Mohamed El-Erian's resignation.http://cnb.cx/1dS6LNx
12/11/13
Holly Thompson
Questcor Pharma $MNK has declared a quarterly cash dividend of $.30/share, payable 1/24/14 to shareholders of record on 1/17/14 .
12/10/13
Holly Thompson
Vail Resorts $MTN target raised premarket to $85 at Barclays; all signs point to a strong ski season. Swish!
12/10/13
Holly Thompson
Broadcom (BRCM) upgraded to Buy from Market Perform at Charter Equity.
12/9/13
Holly Thompson
Analogic Corporation (ALOG) declares $0.10/share quarterly dividend, in line with previous.
12/9/13
Holly Thompson
St. Jude Medical $STJ Board of Directors authorizes $700 mln share repurchase.
12/9/13
Holly Thompson
Gold steadies as traders read Fed taper tea leaves http://cnb.cx/18wJuK2
12/9/13
Holly Thompson
Continental Resources $CLR downgraded to Hold from Buy at Deutsche Bank.
12/9/13
Holly Thompson
Questcor $MNK weakness being attributed to a suggestion that Acthar would only be covered for West syndrome under new Obamacare law.
12/9/13
What suggestion about $MNK? Obamacare does not prescribe drugs. Individual insurers do. What is source?
12/4/13
Holly Thompson
Tyler Tech $TYL announced Boulder, CO has chosen Munis®enterprise resource planning solution to replace its 20 YO public admin system.
11/19/13
Holly Thompson
City of Boston Chooses Tyler Techs' $TYL Munis® ERP Solution to Replace Tax Billing &Collection System. http://bit.ly/1bMNeuT
11/19/13
Holly Thompson
Questcor Pharma $MNK becomes attractive again in the low $50's - CRT Capital.
11/19/13
current range is 55-70. I really doubt it breaks 55. Any buy in the high 50s is good value. Another blowout qtr is right around the corner
11/19/13
FYI qtr 4 for QCOR tends to be the best of the year.
11/18/13
Holly Thompson
Salesforce $CRM reports Q3 earnings of $.09/share, in-line with consensus; revs rose 36.5% yr/yr to $1.08 bln vs $1.05 bln consensus.
11/19/13
I don't understand the obsession with growth when there are no profits. Ignoring stock expense reminds me of a distortion field effect
10/30/13
Holly Thompson
Palm Beach County, Fl Chooses Tyler Technologies' $TYL Records & Documents Solution. http://bit.ly/1adU87I
10/30/13
Holly Thompson
FBR initiates coverage: Endo Pharmaceuticals $ENDP, Market Perform, target is $40. Valeant Pharmaceuticals $VRX, Outperform, target $130.
10/30/13
Holly Thompson
Questcor $MNK target raised to $93 from $84 at Mizuho.
10/30/13
If I might add, wouldn't one think at least one analyst/firm would scare people away rather than hiking PT like crazy today?
10/31/13
And further, don't you think it would be communicated what they are being investigated for? Very fishy on the investigation.
10/30/13
Holly Thompson
Questcor $MNK reports earnings of $1.52/sh, $.32 better than consensus of $1.20; revs rose 68.4% yr/yr to $236.4M vs the $199.8M consensus.
10/29/13
Holly Thompson
Celgene $CELG Earnings Grow Year over Year, View Upped. http://bit.ly/1abYOuD
10/29/13
Holly Thompson
Northern Oil & Gas $NOG target raised to $19 from $17 at Canaccord Genuity following Q3 production beat.
12/9/13
holly whats your read on NOG's recent selloff
10/29/13
Holly Thompson
Actavis $AGN reports Q3 earnings of $2.09/sh, in-line with consensus. Revs rose 56.7% yr/yr to $2.01 bln vs the $2.03 bln consensus.
10/29/13
Holly Thompson
Michael Kors Holdings $KORS will replace NYSE Euronext (NYX) in the S&P 500 after the close of trading on Friday, November 1.
10/24/13
Holly Thompson
Nu Skin $NUS target raised to $127 from $110 at Deutsche Bank.
10/24/13
Holly Thompson
Tyler Tech $TYL target raised to $105 from $90 at Northland Capital following strong Q3.
10/24/13
Holly Thompson
Celgene $CELG beats by $0.03, raises forecast. http://reut.rs/Hh9DWe
10/24/13
Holly Thompson
Alexion Pharma $ALXN beats by $0.04, beats on revs; raises FY13 guidance above consensus. http://bit.ly/1akFIa1
10/23/13
Holly Thompson
Illumina $ILMN Tops Earnings, Ups Guidance http://bit.ly/163EEWt
10/23/13
Holly Thompson
Lumber Liquidators $LL reports earnings of $.73 per share, $.07 better than consensus; revs rose 24.5% yr/yr to $254.3M vs $241.3M consensus
10/23/13
Holly Thompson
Anticipated Earnings Increase for Celgene $CELG. http://onforb.es/1cXsAIg
10/23/13
Holly Thompson
Alexion Pharmaceuticals $ALXN Earnings Expected to Rise http://onforb.es/HeWTQ9
10/23/13
Holly Thompson
Nu Skin $NUS price target raised to $130 from $97 at JPMorgan.